Physician profile
Michael N Mirzabeigi
NPI 1366703258
$71,167.49
in general payments reported to CMS, 2019-2025
14 companies · $42K in 2025
The $42K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $951 · 2020: $771 · 2021: $5,416 · 2022: $5,585 · 2023: $11K · 2024: $4,634 · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $41K · Honoraria: $7,200 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,700 · Food and Beverage: $3,499 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,000 · Travel and Lodging: $45.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $41,000.00 |
| Honoraria | $7,200.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,700.00 |
| Food and Beverage | $3,498.99 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,000.00 |
| Travel and Lodging | $45.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bimini Technologies LLC | $38,500.00 | 2025 | |
| Rti Surgical, INC | $16,421.05 | 2022-2025 | |
| Axogen | $8,963.01 | 2019-2023 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Sientra, INC. | $3,423.85 | 2020-2023 | Sientra High Strength Cohesive Silicone Gel Breast Implant |
| Abbvie INC. | $2,331.73 | 2023-2025 | |
| Kerecis Limited | $313.60 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Mentor Worldwide LLC | $290.71 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $244.57 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tepha INC | $166.08 | 2019 | |
| Baxter Healthcare | $148.54 | 2024 | Perclot |
| Tela Bio, INC. | $136.97 | 2022 | |
| Allergan, INC. | $125.46 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $57.16 | 2019 | |
| Becton, Dickinson and Company | $44.76 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mirzabeigi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.